Career

Don S. Dizon Reflected on ASCO 2025 and Announced Transition to Tufts Medicine

Don Dizon/giving.massgeneral.org

Jun 7, 2025, 05:53

Don S. Dizon Reflected on ASCO 2025 and Announced Transition to Tufts Medicine

Don S. Dizon, Director of Women’s Cancers at Lifespan Cancer Institute, shared a post on LinkedIn:

“Exhausted and home.

Thank you, American Society of Clinical Oncology (ASCO) for a memorable meeting. The community of cancer professionals, researchers, advocates, and survivors is a special one.

So many invested in searching for better – better ways to prevent, screen, detect, treat and support everyone diagnosed, no matter where they live.

Hope all travel back safely, prepared to meet the challenges of our daily professional lives, empowered and inspired by ASCO25. As I leave Brown for Tufts Medicine, I know I will.”

More posts featuring Don S. Dizon on OncoDaily.

American Society of Clinical Oncology ASCO ASCO 2025 ASCO25 Brown University cancer Don S. Dizon Lifespan Cancer Institute OncoDaily Oncology Tufts Medicine

MiNK Therapeutics Stock Surges on Breakthrough Testicular Cancer Remission and iNKT Cell Therapy Progress

Tabelecleucel (Ebvallo) FDA Update: Approval Delayed Despite Positive Phase 3 Data

New Paper Alert: Breakthrough iNKT Cell Therapy Achieves Complete Remission in Metastatic Germ Cell Tumor

"God Invented This" - Pat Soon-Shiong on Cancer Discovery

Kevin Conroy: Oncodetect is Now Covered by Medicare in Stage IV Colorectal Cancer